Skip to content

Bilateral External Oblique Intercostal Plane Block in Laparoscopic Cholecystectomy

Bilateral External Oblique Intercostal Plane Block (EOIPB) an Alternative Analgesic Technique in Patients Scheduled for Laparoscopic Cholecystectomy: A Randomized Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06541613
Enrollment
38
Registered
2024-08-07
Start date
2024-04-25
Completion date
2024-07-15
Last updated
2024-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

External Oblique Intercostal Plane Block, Laparoscopic Cholecystectomy

Keywords

EOIPB, alternative analgesic, laparoscopic cholecystectomy

Brief summary

Pain after laparoscopic cholecystectomy (LC) is a common complaint that prolongs hospital stay and thus increases morbidity. There are three primary sources of pain after LC, incision site, local and systemic effects of pneumoperitoneum, and post cholecystectomy wound to the liver. External oblique intercostal plane block (EOIPB) has recently been described as a novel block for upper abdomen surgery. the probable mechanism of the block with the dyeing of both the anterior and lateral branches of the intercostal nerves T7-T10. This block also provides a dermatomal sensory block at the T6-T10 level in the anterior axillary region and the T6-T9 level in the midline.

Detailed description

EOIPB has the benefit of being performed with the patient supine when compared with QLB and ESPB. It also has an advantage over SIPB in that it produces greater analgesia throughout the midline of the abdomen. The hypothesis of this randomized study is that patients who will undergo EOIPB will have lower opioid consumption in the postoperative period than patients who receive routine multimodal analgesia alone. The study aims to assess pain control in the immediate postoperative period by assessment of Numerical Rating scale (NRS), time for the first analgesic request as well as total morphine intake in the first 24 hours after surgery. Study design: This is a prospective, randomized double blinded control study which will be conducted in department of anesthesia and surgical Intensive care unit at Theodor Bilharz Research Institute after approval by research ethics committee and patient informed consent. 50 patients will be enrolled in the study and divided into two groups either (EOIPB group (E) or Control group (C). Randomization will be done by allocation 1:1 of scheduled cases per day. Sample size: 38 patients

Interventions

DRUGlocal anesthetic injection (bupivacaine)

The in-plane technique with a 22G, 80 mm block needle is used to inject 30 ml of 0.25% bupivacaine into the external oblique intercostal plane on both sides.

OTHERnormal saline injection

the control group will receive 30ml of normal saline bilaterally into the external oblique intercostal plane on both sides

Sponsors

Theodor Bilharz Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

the investigator responsible for block administration will not be aware of the content of the medications prepared whether they are the local anesthetics or normal saline. also the patients will not be aware of the group assignment.

Intervention model description

38 patients will be enrolled in the study and divided into two groups either (EOIPB group (E) or Control group (C). Randomization will be done by allocation 1:1 of scheduled cases per day.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. ASA 1-2. 2. Patients undergoing elective laparoscopic cholecystectomy with estimated pneumoperitoneum time of 60 to 90 min.-

Exclusion criteria

1. Coagulation disorders. 2. Liver/ kidney disease 3. Previous abdominal surgery 4. Infection in the block site 5. Chronic opioid use 6. Local anesthetic (LA) allergy, 7. Pregnancy, or BMI ≥35 kg/m2 8. Duration of surgery (≥ 2.5 h due to surgical complications), -

Design outcomes

Primary

MeasureTime frameDescription
total morphine consumptionthe first 24 hours postoperativelythe total analgesic (morphine) requirements in the first 24 hours postoperatively will be calculated

Secondary

MeasureTime frameDescription
NRS6 hours postoperativelyNumerical rating scale for pain recorded at 15,30, 60 minutes postopetaively.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026